AU2119101A - Ligand chelated paramagnetic mri contrast agents - Google Patents
Ligand chelated paramagnetic mri contrast agentsInfo
- Publication number
- AU2119101A AU2119101A AU21191/01A AU2119101A AU2119101A AU 2119101 A AU2119101 A AU 2119101A AU 21191/01 A AU21191/01 A AU 21191/01A AU 2119101 A AU2119101 A AU 2119101A AU 2119101 A AU2119101 A AU 2119101A
- Authority
- AU
- Australia
- Prior art keywords
- contrast agents
- mri contrast
- chelated paramagnetic
- ligand chelated
- paramagnetic mri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16099099P | 1999-10-22 | 1999-10-22 | |
US16093399P | 1999-10-22 | 1999-10-22 | |
US60160990 | 1999-10-22 | ||
US60160933 | 1999-10-22 | ||
PCT/US2000/041385 WO2001030398A2 (en) | 1999-10-22 | 2000-10-20 | Ligand chelated paramagnetic mri contrast agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2119101A true AU2119101A (en) | 2001-05-08 |
Family
ID=26857346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU21191/01A Abandoned AU2119101A (en) | 1999-10-22 | 2000-10-20 | Ligand chelated paramagnetic mri contrast agents |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2119101A (en) |
WO (1) | WO2001030398A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI284539B (en) | 2001-07-30 | 2007-08-01 | Epix Pharm Inc | A method for making a magnetic resonance (MR) imaging agent, a MR imaging contrast agent, a method for altering stability of a peptide and a modified peptide |
US6987270B2 (en) | 2003-05-07 | 2006-01-17 | General Electric Company | Method to account for event losses due to positron range in positron emission tomography and assay of positron-emitting isotopes |
US9339559B2 (en) | 2005-09-09 | 2016-05-17 | Georgia State University Research Foundation, Inc. | Targeted contrast agents and methods for targeting contrast agents |
EP1928507B1 (en) * | 2005-09-09 | 2015-11-11 | Georgia State University Research Foundation, Inc. | Targeted contrast agents and methods for targeting contrast agents |
EP2518155B1 (en) | 2006-08-04 | 2014-07-23 | Georgia State University Research Foundation, Inc. | Enzyme sensors, methods for preparing and using such sensors, and methods of detecting protease activity |
CA2671431C (en) | 2006-12-14 | 2019-03-26 | Georgia State University Research Foundation, Inc. | Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity |
EP2257316B1 (en) | 2008-04-02 | 2018-11-07 | Georgia State University Research Foundation, Inc. | Contrast agents, methods for preparing contrast agents, and methods of imaging |
WO2011006985A1 (en) * | 2009-07-16 | 2011-01-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors |
US9956304B2 (en) | 2012-06-05 | 2018-05-01 | Georgia State University Research Foundation, Inc. | Contrast agents, methods for preparing contrast agents, and methods of imaging |
WO2023279073A1 (en) * | 2021-07-01 | 2023-01-05 | Amicus Therapeutics, Inc. | Neurotensin variants and tagged proteins comprising neurotensin or sortilin propeptide |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995022341A1 (en) * | 1994-02-18 | 1995-08-24 | Mallinckrodt Medical, Inc. | Labelled peptide compounds |
US6312661B1 (en) * | 1997-02-03 | 2001-11-06 | Mallinckrodt Inc. | Method for the detection and localization of ductal exocrine pancreas tumours |
EP1194444A2 (en) * | 1999-06-24 | 2002-04-10 | BioSynthema Inc. | Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
-
2000
- 2000-10-20 WO PCT/US2000/041385 patent/WO2001030398A2/en active Application Filing
- 2000-10-20 AU AU21191/01A patent/AU2119101A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001030398A2 (en) | 2001-05-03 |
WO2001030398A3 (en) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145839A0 (en) | ESTROGEN RECEPTOR-β LIGANDS | |
HUP0202442A3 (en) | Multiple cytokine-antibody complexes | |
AU5753601A (en) | Functional mri agents for cancer imaging | |
AU2001276956A1 (en) | Macrocyclic mri contrast agents | |
IL153539A0 (en) | Protein complexes and methods for the preparation thereof | |
AU2119101A (en) | Ligand chelated paramagnetic mri contrast agents | |
GB9924205D0 (en) | Magnetic fastener | |
GB9802022D0 (en) | Complexing agents | |
GB9923928D0 (en) | Coils integrated in ic-package | |
SG87181A1 (en) | Magnetic media tester | |
GB0012054D0 (en) | Ligands | |
GB9912743D0 (en) | Method and kit for ligand assay | |
GB9915114D0 (en) | Trailers | |
AU3225900A (en) | Ph sensitive mri contrast agents | |
IL150890A0 (en) | Novel ligands and methods for preparing same | |
GB2352524B (en) | Trailer noseweight indicator | |
AU2316100A (en) | Complexing agents | |
GB9927157D0 (en) | Releasable Ligand | |
GB9927014D0 (en) | Mr probes | |
GB9923812D0 (en) | Ligand design | |
GB0004962D0 (en) | Macrocyclic ligands and complexes thereof | |
GB9927536D0 (en) | Magnetic motor | |
EP1240358A4 (en) | T1 receptor-like ligand ii and uses thereof | |
GB9903823D0 (en) | Schiefs base complexes | |
GB2355012B (en) | Paramagnetic polymer practice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |